Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gold Fields Limited (GFI) vs Illumina, Inc. (ILMN) Price & Performance

Gold Fields LimitedTrade
Illumina, Inc.Trade

Price performance (Past 24H)

Key statistics

Gold Fields Limited vs Illumina, Inc. — how do they compare? Gold Fields Limited trades at $36.83 (market cap $31.87B), while Illumina, Inc. trades at $268.11 (market cap $39.95B). The key difference: Illumina, Inc. is the larger of the two by market cap, and Gold Fields Limited pays a 6% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gold Fields Limited for 49 Days and Illumina, Inc. for 83 Days on average.

GFIILMN
Market Cap
$31.87B$39.95B
Volume
4,169,6513,169,503
Sector
Basic MaterialsHealth
52-Week High
$61.52$293.69
52-Week Low
$31.25$91.00
Typical Hold Time
49 Days83 Days
Enterprise Value
$32.47B$41.31B
Dividend Yield
6%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gold Fields Limited

Gold Fields (GFI) trades at $35.05, down 3.1% amid market reaction to its rejected $27 billion bid for Northern Star. The stock shows a bearish technical signal with key support at $34-$35, while fundamentals remain strong with a 40.76% net margin and low P/E of 7.3. Recent earnings saw mixed results, with one beat and three misses against expectations.

The outlook is balanced: robust cash flow and high profitability support upside toward the $52.75 analyst target, but acquisition uncertainty and technical weakness pose near-term risks. Investor sentiment is cautious pending clarity on M&A strategy and capital allocation.

Illumina, Inc.

Illumina (ILMN) trades at $267.76, down 2.11% today but remains near recent highs after a strong 94.9% YTD rally. The stock shows bullish technical momentum with recent earnings beats and improved profitability, with net income turning positive to $850 million in 2025 after previous losses. S&P 500 inclusion in September 2026 and growing AI integration in genomics provide positive catalysts, though valuation metrics remain elevated with a P/E of 49.36.

Outlook remains positive with analyst consensus favoring Buy ratings (54%) and a $241 price target, though current price exceeds consensus. Key opportunities include sequencing growth and AI adoption, while risks include China headwinds, margin pressure, and high valuation multiples requiring sustained execution to justify premium pricing.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GFI
5% Buy95% Sell
Avg holding period · 49 Days
ILMN
96% Buy4% Sell
Avg holding period · 83 Days

Top news

Latest headlines on both assets

About Gold Fields Limited

Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is primarily involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.

Read more on GFI →

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Read more on ILMN →